Related Experiment Video
Updated: Jul 11, 2026
11:35
Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)
Published on: August 21, 2016
Novel methods for detecting epistasis in pharmacogenomics studies
Alison A Motsinger1, Marylyn D Ritchie, David M Reif
1North Carolina State University, Bioinformatics Research Center, Department of Statistics, Raleigh, NC 27695, USA.
Pharmacogenomics
|October 11, 2007
Summary
Investigating gene-gene and gene-environment interactions is crucial for understanding complex traits in pharmacogenomics. This review highlights data-mining tools and methods to detect these genetic interactions in epidemiological studies.
Area of Science:
- Pharmacogenomics
- Genetic Epidemiology
- Complex Trait Genetics
Background:
- Complex phenotypes are influenced by gene-gene (epistasis) and gene-environment interactions.
- Understanding these interactions is vital for personalized medicine and predicting drug response.
- Traditional genetic association studies often overlook these complex interactions.
Purpose of the Study:
- To review data-mining tools for detecting gene-gene and gene-environment interactions in genetic epidemiology.
- To provide an organized collection of successful applications of these methods.
- To guide researchers in incorporating interaction analyses into their genetic studies.
Main Methods:
- Survey of novel statistical and computational methods for interaction detection.
- Discussion of data-mining approaches applicable to genetic epidemiology.
- Literature review of successful applications in identifying genetic interactions.
Main Results:
- Several classes of novel methods for detecting epistasis and gene-environment interactions are available.
- Successful applications demonstrate the utility of these methods in real-world genetic studies.
- Guidance is provided for integrating interaction analysis into research workflows.
Conclusions:
- Incorporating gene-gene and gene-environment interaction analyses enhances the understanding of complex trait genetics.
- Utilizing appropriate data-mining tools is essential for robust interaction detection.
- This review aims to empower researchers to develop comprehensive genetic analysis plans.
More Related Videos
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:09Epistasis Analysis
Although Mendel chose seven unrelated traits in peas to study gene segregation, most traits involve multiple gene interactions that create a spectrum of phenotypes. When the interaction of various genes or alleles at different locations influences a phenotype, this is called epistasis. Epistasis often involves one gene masking or interfering with the expression of another (antagonistic epistasis). Epistasis often occurs when different genes are part of the same biochemical pathway. The...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...